Rafael Lopez, oncologist: With a blood test we expect to be able to identify the weaknesses of almost all tumors'Liquid biopsy technology is revolutionizing cancer treatment by enabling earlier detection and better prognostication.
Cancer breakthrough as scientists discover 'switch', reverse diseaseA scientific breakthrough allows the reversal of cancer cells, potentially leading to less toxic treatment options.
Immunotherapy achieves remarkable survival rates in a handful of tumorsImmunotherapy has significantly improved prognosis and survival rates for patients with metastatic melanoma over the past 15 years.
New Chief of Division of Hematology and Oncology Named - News CenterHidayatullah G. Munshi has been appointed as chief of the Division of Hematology and Oncology, effective October 15.
Rafael Lopez, oncologist: With a blood test we expect to be able to identify the weaknesses of almost all tumors'Liquid biopsy technology is revolutionizing cancer treatment by enabling earlier detection and better prognostication.
Cancer breakthrough as scientists discover 'switch', reverse diseaseA scientific breakthrough allows the reversal of cancer cells, potentially leading to less toxic treatment options.
Immunotherapy achieves remarkable survival rates in a handful of tumorsImmunotherapy has significantly improved prognosis and survival rates for patients with metastatic melanoma over the past 15 years.
New Chief of Division of Hematology and Oncology Named - News CenterHidayatullah G. Munshi has been appointed as chief of the Division of Hematology and Oncology, effective October 15.
She wanted to be a mom. So she chose a cancer treatment that gave her a chanceMaggie Loucks' journey highlights the emotional impact of breast cancer on motherhood aspirations and the advancements in targeted cancer treatments.
When I delivered the worst of news to my dying patient, she cried but not about her prognosis | Ranjana SrivastavaThe article reflects on a compassionate yet painful meeting between a doctor and a terminally ill patient, highlighting the emotional toll of delivering bad news.
She wanted to be a mom. So she chose a cancer treatment that gave her a chanceMaggie Loucks' journey highlights the emotional impact of breast cancer on motherhood aspirations and the advancements in targeted cancer treatments.
When I delivered the worst of news to my dying patient, she cried but not about her prognosis | Ranjana SrivastavaThe article reflects on a compassionate yet painful meeting between a doctor and a terminally ill patient, highlighting the emotional toll of delivering bad news.
Quibim raises $50M to develop AI models for medical imaging | TechCrunchQuibim raised $50 million to enhance AI diagnostic accuracy in medical imaging, planning U.S. expansion and development of digital twins of the human body.
When Cancer' Gets in the Way of TreatmentThe term 'cancer' can evoke intense fear and anxiety in patients, influencing their understanding and reactions to their diagnosis.
Amazing' trial shows drug combination stops lung cancer advancing for longerA new drug combination significantly extends progression-free survival in advanced lung cancer patients compared to standard treatment.
Tak Mak, immunologist: The immune system is the orchestra for most of life's symphonies'Immunotherapy represents a revolutionary advancement in cancer treatment, surpassing traditional methods like chemotherapy and radiotherapy in efficacy.
Top Cancer Hospitals for Comprehensive Treatment in 2024Selecting the right hospital for cancer treatment involves considering various factors like quality of care and advanced treatment technology.
Richard Pazdur, FDA Cancer Chief, Discusses 25 Years of InnovationCancer treatment has evolved significantly over the past 25 years, enabling more targeted therapies and improved patient outcomes.
Investigating New Treatments for Rare Skin Lymphomas - News CenterA novel fusion protein therapy shows promise as an effective treatment for cutaneous T-cell lymphomas in a recent clinical trial.
Amazing' trial shows drug combination stops lung cancer advancing for longerA new drug combination significantly extends progression-free survival in advanced lung cancer patients compared to standard treatment.
Tak Mak, immunologist: The immune system is the orchestra for most of life's symphonies'Immunotherapy represents a revolutionary advancement in cancer treatment, surpassing traditional methods like chemotherapy and radiotherapy in efficacy.
Top Cancer Hospitals for Comprehensive Treatment in 2024Selecting the right hospital for cancer treatment involves considering various factors like quality of care and advanced treatment technology.
Richard Pazdur, FDA Cancer Chief, Discusses 25 Years of InnovationCancer treatment has evolved significantly over the past 25 years, enabling more targeted therapies and improved patient outcomes.
Investigating New Treatments for Rare Skin Lymphomas - News CenterA novel fusion protein therapy shows promise as an effective treatment for cutaneous T-cell lymphomas in a recent clinical trial.
The unknowns surrounding the mysterious rise of cancer in young adultsThe rise of cancer in young adults is alarming, with nearly 80% increase in tumors under 50 years in the last 30 years.
Kate Middleton Says Her Cancer Is in Remission. Here's What That MeansPrincess Kate Middleton announces she is in remission from cancer, signaling a positive turn in her health journey, focused on recovery.
OneCell Diagnostics bags $16M to help limit cancer reoccurrence using AI | TechCrunchOneCell Diagnostics aims to revolutionize cancer recurrence detection through innovative blood-based biopsy techniques.
The unknowns surrounding the mysterious rise of cancer in young adultsThe rise of cancer in young adults is alarming, with nearly 80% increase in tumors under 50 years in the last 30 years.
Kate Middleton Says Her Cancer Is in Remission. Here's What That MeansPrincess Kate Middleton announces she is in remission from cancer, signaling a positive turn in her health journey, focused on recovery.
OneCell Diagnostics bags $16M to help limit cancer reoccurrence using AI | TechCrunchOneCell Diagnostics aims to revolutionize cancer recurrence detection through innovative blood-based biopsy techniques.
Health Care AI Requires a Lot of Expensive Humans to RunAI algorithms in healthcare must be continuously monitored to function effectively, especially in critical patient discussions.
UK medtech startup 52North bags 5.7M funding - Silicon Canals52North secured $6M in funding to enhance oncology urgent care pathways and advance its innovative products.
Health Care AI Requires a Lot of Expensive Humans to RunAI algorithms in healthcare must be continuously monitored to function effectively, especially in critical patient discussions.
UK medtech startup 52North bags 5.7M funding - Silicon Canals52North secured $6M in funding to enhance oncology urgent care pathways and advance its innovative products.
GSK to buy US cancer drug firm IDRx for up to $1.15bnGSK is acquiring IDRx to strengthen its oncology business and address treatment gaps in gastrointestinal cancers.
My Traumatized Dog and I Had Trust IssuesThe author reflects on the contrast between medical expertise and the emotional connection needed in healing.
A First-of-Its-Kind Explainable AI Model Detects Brain CancerA new study combines explainable AI with camouflage algorithms to improve brain cancer detection, representing a breakthrough at the intersection of neuroscience and oncology.
Pharmacologic restoration of GTP hydrolysis by mutant RASTri-complex inhibitors can stimulate GTP hydrolysis in RAS mutants, enhancing therapeutic effectiveness for specific mutations.
Breakthrough by William Pao review the drugs do workCreative innovation in drug development becomes a transformative force in medicine, driven by personal dedication and often serendipitous discoveries.
New cervical cancer treatment regime cuts risk of dying from disease by 40%'New treatment for cervical cancer reduces risk of dying by 40%, marking a significant breakthrough in the last 25 years of medical research.
V. Craig Jordan, Who Discovered a Key Breast Cancer Drug, Dies at 76V. Craig Jordan's discovery of using tamoxifen to block breast cancer growth revolutionized oncology and saved many lives.
Men get breast cancer, too. But they can't always access new drugs | CBC NewsWarren Kotler has outlived his terminal cancer prognosis through treatment and lifestyle changes, exemplifying resilience amid uncertainty about future treatment efficacy.
V. Craig Jordan, Who Discovered a Key Breast Cancer Drug, Dies at 76V. Craig Jordan's discovery of using tamoxifen to block breast cancer growth revolutionized oncology and saved many lives.
Men get breast cancer, too. But they can't always access new drugs | CBC NewsWarren Kotler has outlived his terminal cancer prognosis through treatment and lifestyle changes, exemplifying resilience amid uncertainty about future treatment efficacy.
SEC Charges Ipsen Worker for Insider Trading Tied to $247M Epizyme Acquisition - MedCity NewsIpsen is focused on expanding its oncology portfolio via acquisitions, now marred by insider trading allegations against an employee.Dishant Gupta is charged with insider trading connected to Ipsen's acquisition of Epizyme due to his knowledge of non-public information.
Gasdermin D-mediated metabolic crosstalk promotes tissue repair - NatureInterdisciplinary collaboration in medical research enhances innovation and problem-solving capabilities.
Resilience Raises $25M to Expand Remote Oncology Patient MonitoringResilience raised $25 million for oncology remote monitoring, expanding in Europe.
PhoreMost $12M Series B Financing to Advance Next-Gen Degrader ProgramsPhoreMost has raised $12 million in Series B funding, advancing its pipeline for oncology and inflammatory diseases.The company aims to move cancer treatment programs into preclinical development with this new funding.
Resilience Raises $25M to Expand Remote Oncology Patient MonitoringResilience raised $25 million for oncology remote monitoring, expanding in Europe.
PhoreMost $12M Series B Financing to Advance Next-Gen Degrader ProgramsPhoreMost has raised $12 million in Series B funding, advancing its pipeline for oncology and inflammatory diseases.The company aims to move cancer treatment programs into preclinical development with this new funding.
3 Penny Stocks to Buy With $500Penny stocks can yield significant returns but come with high risk; only invest what you can afford to lose.
How to Find the Right Oncologist for YouChoosing the right oncologist is crucial for cancer treatment outcomes and patient satisfaction.
AI assistance for planning cancer treatmentAI algorithms are aiding oncologists in predicting responders to immunotherapy, improving treatment outcomes.
Study Identifies Disparities in End-of-Life Care for Lung Cancer Patients - News CenterRacial and ethnic minorities with lung cancer experience higher intensity of end-of-life care compared to white patients.
Resveratrol: A Ray of Hope in the Battle Against Oral CancerResveratrol shows promise in combating oral cancer.
SoftBank forms AI healthcare JV in Japan with Tempus | TechCrunchSoftBank Group and Tempus form joint venture in Japan to develop AI-powered personalized medical services, starting with oncology.